Teresa Macarulla

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

L. Visa, Mónica Guillot Morales, Elena Brozos Vázquez, 2024, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

HLA-A*02:01 allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of the HLA variation in PDAC

L. Alonso, A. Carrato, A. Tardón, 2024, medRxiv.

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

R. Dienstmann, O. Díez, S. Gutiérrez‐Enríquez, 2024, Genome medicine.